A. Veyre

Phase II scintigraphic clinical trial of malignant melanoma and metastases with iodine-123-N-(2-diethylaminoethyl 4-iodobenzamide).

J. Michelot, Marie‐France Moreau, A. Veyre et al. · PubMed · 1993 · 119 citations

Primary Melanomas, Surgical Oncology, Engineering +15

Technetium-99m-sestamibi uptake in breast tumor and associated lymph nodes.

J. Maublant, M de Latour, D. Mestas et al. · PubMed · 1996 · 106 citations

Mechanism of uptake of technetium-tetrofosmin. II: Uptake into isolated adult rat heart mitochondria

Antoine Younès, Jean Arthur Songadele, J. Maublant et al. · Journal of Nuclear Cardiology · 1995 · 106 citations

Mitochondrial Function, Biochemistry, Medicine +5

In vitro uptake of technetium-99m-teboroxime in carcinoma cell lines and normal cells: comparison with technetium-99m-sestamibi and thallium-201.

Jean C. Maublant, Zheng Zhang, Maryse Rapp et al. · PubMed · 1993 · 100 citations

Vitro Uptake, Pathology, Tumor Biology +16

Synthesis and evaluation of new iodine-125 radiopharmaceuticals as potential tracers for malignant melanoma.

J. Michelot, Marie‐France Moreau, P.G. Labarre et al. · PubMed · 1991 · 89 citations

Engineering, Malignant Melanoma, New Iodine-125 Radiopharmaceuticals +18